首页> 美国卫生研究院文献>BMC Musculoskeletal Disorders >Individualized patient decision-aid for immunosuppressive drugs in women with lupus nephritis: study protocol of a randomized controlled trial
【2h】

Individualized patient decision-aid for immunosuppressive drugs in women with lupus nephritis: study protocol of a randomized controlled trial

机译:狼疮性肾炎妇女免疫抑制药物的个性化患者决策辅助:一项随机对照试验的研究方案

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundSystemic Lupus erythematosus (SLE), also commonly referred to as lupus, is a rare, but sometimes, fatal disease, that primarily affects young women. Lupus nephritis, a common manifestation of lupus, is more common and more devastating in patients of minority race/ethnicity. Patients have negative views of immunosuppressive drugs for lupus nephritis due to a concern about side effects and under-appreciation of its benefit. We designed a study to assess the effectiveness of individualized, computerized patient decision-aid for immunosuppressive drugs for lupus nephritis compared to a standard pamphlet for patient decision-making.
机译:背景系统性红斑狼疮(SLE),通常也称为狼疮,是一种罕见的,但有时是致命的疾病,主要影响年轻女性。狼疮性肾炎是狼疮的一种常见表现,在少数族裔/种族患者中更为常见且更具破坏性。由于对副作用和对其益处的重视不足,患者对狼疮性肾炎的免疫抑制药物持消极看法。我们设计了一项研究,以评估针对个性化,计算机化的狼疮性肾炎免疫抑制药物的患者决策辅助工具(与用于患者决策的标准手册相比)的有效性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号